Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Learn ways to automate your savings for effortless financial growth. Simplify your saving habits and watch your funds grow.
17,672 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Investing in space stocks is no longer a sci‑fi dream. This guide breaks down where will rocket stock likely head in ...
As AI reshapes the job landscape in early 2026, workers face displacement and investors recalibrate. This report expl...
AMD’s AI accelerator cycle could change the stock picture if the MI350 ramp and MI450 shipments hit on schedule. This...
NVIDIA is signaling a bold push into faster AI inference with a new chip design. This move could reshape cloud comput...
As AI demand soars, Micron sits at the center of memory hardware used in data centers. This article breaks down wheth...
Nu Holdings faced a sharp February drop as U.S. expansion uncertainty and broader macro headwinds collided with stron...
Investors often wonder where will Realty Income head in ten years. This article breaks down how its net-lease model, ...
When a big fund trims a REIT stake, investors watch for clues about rental income and stock performance. This article...
Investor Kevin O’Leary warns that bringing a parent to a job interview signals a loss of independence, insisting that...
Artificial intelligence (ai) is moving from pilot projects to mission-critical software. This article examines a lead...
BlackRock's Larry Fink presents two stark paths for oil and markets tied to the Iran conflict, challenging households...